[
  {
    "ts": "2026-01-25T09:46:28+00:00",
    "headline": "Here Are the Top Four Blue-Chip Stocks To Buy in 2026, According to WarrenAI",
    "summary": "Investing.com -- Blue chip stocks in the healthcare sector are showing exceptional growth potential according to recent rankings from WarrenAI. The analysis highlights four standout companies that combine strong fundamentals with significant upside potential, making them attractive options in today’s market.",
    "url": "https://finance.yahoo.com/news/top-four-blue-chip-stocks-094628288.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "d0e25c9a-2e58-36e1-8573-abeb73f2d7bb",
      "content": {
        "id": "d0e25c9a-2e58-36e1-8573-abeb73f2d7bb",
        "contentType": "STORY",
        "title": "Here Are the Top Four Blue-Chip Stocks To Buy in 2026, According to WarrenAI",
        "description": "",
        "summary": "Investing.com -- Blue chip stocks in the healthcare sector are showing exceptional growth potential according to recent rankings from WarrenAI. The analysis highlights four standout companies that combine strong fundamentals with significant upside potential, making them attractive options in today’s market.",
        "pubDate": "2026-01-25T09:46:28Z",
        "displayTime": "2026-01-25T09:46:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-four-blue-chip-stocks-094628288.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-four-blue-chip-stocks-094628288.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "COR"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "CI"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-25T14:14:29+00:00",
    "headline": "Merck & Co., Inc. (MRK) and CEPI Launch Effort to Make Ebola Vaccine Cheaper and Easier to Distribute",
    "summary": "Merck & Co., Inc. (NYSE:MRK) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported that Merck & Co., Inc. (NYSE:MRK)’s MSD unit and the Coalition for Epidemic Preparedness Innovations (CEPI) said on January 21 that they are launching a $30 million program to create an updated version of Merck’s Ebola vaccine. The idea […]",
    "url": "https://finance.yahoo.com/news/merck-co-inc-mrk-cepi-141429621.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "27d72735-9187-3bb3-bdfe-44bad4d17daf",
      "content": {
        "id": "27d72735-9187-3bb3-bdfe-44bad4d17daf",
        "contentType": "STORY",
        "title": "Merck & Co., Inc. (MRK) and CEPI Launch Effort to Make Ebola Vaccine Cheaper and Easier to Distribute",
        "description": "",
        "summary": "Merck & Co., Inc. (NYSE:MRK) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported that Merck & Co., Inc. (NYSE:MRK)’s MSD unit and the Coalition for Epidemic Preparedness Innovations (CEPI) said on January 21 that they are launching a $30 million program to create an updated version of Merck’s Ebola vaccine. The idea […]",
        "pubDate": "2026-01-25T14:14:29Z",
        "displayTime": "2026-01-25T14:14:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/67016191d6d2df48fd6f8c9ec632b347",
          "originalWidth": 1920,
          "originalHeight": 1186,
          "caption": "Merck & Co., Inc. (MRK) and CEPI Launch Effort to Make Ebola Vaccine Cheaper and Easier to Distribute",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vJ7lKbloSPByVfgD_gqgZg--~B/aD0xMTg2O3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/67016191d6d2df48fd6f8c9ec632b347.cf.webp",
              "width": 1920,
              "height": 1186,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/szs6fG45A8w_rlV8N_NBzA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/67016191d6d2df48fd6f8c9ec632b347.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-co-inc-mrk-cepi-141429621.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-co-inc-mrk-cepi-141429621.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-25T19:30:00+00:00",
    "headline": "Merck No Longer in Talks to Buy Revolution Medicines",
    "summary": "The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at around $30 billion.",
    "url": "https://www.wsj.com/health/pharma/merck-no-longer-in-talks-to-buy-revolution-medicines-b8d5e5eb?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "5284dde9-b3bf-3341-b74e-6afb7b3b788c",
      "content": {
        "id": "5284dde9-b3bf-3341-b74e-6afb7b3b788c",
        "contentType": "STORY",
        "title": "Merck No Longer in Talks to Buy Revolution Medicines",
        "description": "",
        "summary": "The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at around $30 billion.",
        "pubDate": "2026-01-25T19:30:00Z",
        "displayTime": "2026-01-25T19:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/5284dde9-b3bf-3341-b74e-6afb7b3b788c/merck-no-longer-in-talks-to.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/0db0b0e48725298475a4d95919433bf5",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9yRXbT6u6MBG0fWb62t0Qg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/0db0b0e48725298475a4d95919433bf5.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GHs18DTuXxpJ0Gxn.g63lQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/0db0b0e48725298475a4d95919433bf5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/merck-no-longer-in-talks-to-buy-revolution-medicines-b8d5e5eb?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVMD"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]